Increased miR-16 expression induced by hepatitis C virus infection promotes liver fibrosis through downregulation of hepatocyte growth factor and Smad7

Archives of Virology

Volumn 160, Issue 8, 2015, Pages 2043-2050

  Zhu, Bin ^a   Wei, Xiao xia ^a   Wang, Tian bao ^a   Zhou, Yan cai ^a   Liu, A min ^a   Zhang, Guang wen ^a  

^a Xin Xiang Medical University   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRIDAE; HEPATITIS C VIRUS;

MICRORNA; MIRN16 MICRORNA, HUMAN; SCATTER FACTOR; SMAD7 PROTEIN; SMAD7 PROTEIN, HUMAN;

ADULT; COMPLICATION; DOWN REGULATION; FEMALE; GENETICS; HEPACIVIRUS; HEPATITIS C; HUMAN; LIVER CIRRHOSIS; MALE; METABOLISM; MIDDLE AGED; PHYSIOLOGY; VIROLOGY;

ADULT; DOWN-REGULATION; FEMALE; HEPACIVIRUS; HEPATITIS C; HEPATOCYTE GROWTH FACTOR; HUMANS; LIVER CIRRHOSIS; MALE; MICRORNAS; MIDDLE AGED; SMAD7 PROTEIN;

EID: 84938960555     PISSN: 03048608     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00705-015-2474-3     Document Type: Article

References (26)

1. Brase JC, Wuttig D, Kuner R, Sultmann H (2010) Serum microRNAs as non-invasive biomarkers for cancer. Mol Cancer 9:306
2. Budhu A, Jia HL, Forgues M, Liu CG, Goldstein D, Lam A, Zanetti KA, Ye QH, Qin LX, Croce CM (2008) Identification of metastasis-related microRNAs in hepatocellular carcinoma. Hepatology 47:897–907
3. Cermelli S, Ruggieri A, Marrero JA, Ioannou GN, Beretta L (2011) Circulating microRNAs in patients with chronic hepatitis C and non-alcoholic fatty liver disease. PloS One 6:e23937
4. Chang C-C, Lin C-C, Hsieh W-L, Lai H-W, Tsai C-H, Cheng Y-W (2014) MicroRNA expression profiling in PBMCs: a potential diagnostic biomarker of chronic hepatitis C. Dis Markers 2014:1–9
5. Chung AC, Huang XR, Meng X, Lan HY (2010) miR-192 mediates TGF-β/Smad3-driven renal fibrosis. J Am Soc Nephrol 21:1317–1325
6. Dooley S, Hamzavi J, Breitkopf K, Wiercinska E, Said HM, Lorenzen J, Ten Dijke P, Gressner AM (2003) Smad7 prevents activation of hepatic stellate cells and liver fibrosis in rats. Gastroenterology 125:178–191
7. Fognani E, Giannini C, Piluso A, Gragnani L, Monti M, Caini P, Ranieri J, Urraro T, Triboli E, Laffi G (2013) Role of microRNA profile modifications in hepatitis C virus-related mixed cryoglobulinemia. PloS One 8:e62965
8. Funakoshi H, Nakamura T (2003) Hepatocyte growth factor: from diagnosis to clinical applications. Clin Chim Acta 327:1–23
9. Ikeda K, Saitoh S, Suzuki Y, Kobayashi M, Tsubota A, Koida I, Arase Y, Fukuda M, Chayama K, Murashima N (1998) Disease progression and hepatocellular carcinogenesis in patients with chronic viral hepatitis: a prospective observation of 2215 patients. J Hepatol 28:930–938
10. Z-z Jiang, G-y Xia, Zhang Y, Dong L, B-z He, J-g Sun (2013) Attenuation of hepatic fibrosis through ultrasound-microbubble-mediated HGF gene transfer in rats. Clin Imaging 37:104–110
11. Kinoshita T, Tashiro K, Nakamura T (1989) Marked increase of HGF mRNA in non-parenchymal liver cells of rats treated with hepatotoxins. Biochem Biophys Res Commun 165:1229–1234
12. Li Q, Weng J, Mohan RR, Bennett GL, Schwall R, Wang Z-F, Tabor K, Kim J, Hargrave S, Cuevas KH (1996) Hepatocyte growth factor and hepatocyte growth factor receptor in the lacrimal gland, tears, and cornea. Invest Ophthalmol Vis Sci 37:727–739
13. Liaw YF, Tai DI, Chu CM, Chen TJ (1988) The development of cirrhosis in patients with chronic type B hepatitis: a prospective study. Hepatology 8:493–496
14. Matsuda Y, Matsumoto K, Yamada A, Ichida T, Asakura H, Komoriya Y, Nishiyama E, Nakamura T (1997) Preventive and therapeutic effects in rats of hepatocyte growth factor infusion on liver fibrosis/cirrhosis. Hepatology 26:81–89
15. Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, Pogosova-Agadjanyan EL, Peterson A, Noteboom J, O’Briant KC, Allen A (2008) Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci 105:10513–10518
16. Niederau C, Lange S, Heintges T, Erhardt A, Buschkamp M, Hürter D, Nawrocki M, Kruska L, Hensel F, Petry W (1998) Prognosis of chronic hepatitis C: results of a large, prospective cohort study. Hepatology 28:1687–1695
17. Poynard T, Bedossa P, Opolon P (1997) Natural history of liver fibrosis progression in patients with chronic hepatitis C. Lancet 349:825–832
18. Roderburg C, Luedde M, Cardenas DV, Vucur M, Mollnow T, Zimmermann HW, Koch A, Hellerbrand C, Weiskirchen R, Frey N (2013) miR-133a mediates TGF-b-dependent de-repression of collagen-synthesis in hepatic stellate cells during liver fibrosis. J Hepatol 58:S245–S246
19. Shao R-X, Hoshida Y, Otsuka M, Kato N, Tateishi R, Teratani T, Shiina S, Taniguchi H, Moriyama M, Kawabe T (2005) Hepatic gene expression profiles associated with fibrosis progression and hepatocarcinogenesis in hepatitis C patients. World J Gastroenterol 11:1995–1999
20. Sukata T, Sumida K, Kushida M, Ogata K, Miyata K, Yabushita S, Uwagawa S (2011) Circulating microRNAs, possible indicators of progress of rat hepatocarcinogenesis from early stages. Toxicol Lett 200:46–52
21. Trebicka J, Anadol E, Elfimova N, Strack I, Roggendorf M, Viazov S, Wedemeyer I, Drebber U, Rockstroh J, Sauerbruch T (2013) Hepatic and serum levels of miR-122 after chronic HCV-induced fibrosis. J Hepatol 58:234–239
22. Tsukada S, Parsons CJ, Rippe RA (2006) Mechanisms of liver fibrosis. Clin Chim Acta 364:33–60
23. Verrecchia F, Chu M-L, Mauviel A (2001) Identification of novel TGF-b/Smad gene targets in dermal fibroblasts using a combined cDNA microarray/promoter transactivation approach. J Biol Chem 276:17058–17062
24. Wu G, Yu F, Xiao Z, Xu K, Xu J, Tang W, Wang J, Song E (2011) Hepatitis B virus X protein downregulates expression of the miR-16 family in malignant hepatocytes in vitro. Br J Cancer 105:146–153
25. Yang Q, Fu S, Wang J (2014) Hepatitis C virus infection decreases the expression of Toll-like receptors 3 and 7 via upregulation of miR-758. Arch Virol 159:2997–3003
26. Zarnegar R, DeFrances MC, Kost DP, Lindroos P, Michalopoulos GK (1991) Expression of hepatocyte growth factor mRNA in regenerating rat liver after partial hepatectomy. Biochem Biophys Res Commun 177:559–565